Original Research
Published on 14 Feb 2023
Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database
in Pharmacoepidemiology

- 3,974 views
- 9 citations
Original Research
Published on 14 Feb 2023
in Pharmacoepidemiology
Original Research
Published on 10 Feb 2023
in Pharmacoepidemiology
Original Research
Published on 07 Feb 2023
in Pharmacoepidemiology
Original Research
Published on 06 Feb 2023
in Pharmacoepidemiology
Original Research
Published on 30 Jan 2023
in Pharmacoepidemiology
Original Research
Published on 26 Jan 2023
in Pharmacoepidemiology
Brief Research Report
Published on 17 Jan 2023
in Pharmacoepidemiology
Original Research
Published on 12 Jan 2023
in Pharmacoepidemiology
Original Research
Published on 12 Jan 2023
in Pharmacoepidemiology
Original Research
Published on 12 Jan 2023
in Pharmacoepidemiology
Original Research
Published on 10 Jan 2023
in Pharmacoepidemiology
Original Research
Published on 06 Jan 2023
in Pharmacoepidemiology
Original Research
Published on 05 Jan 2023
in Pharmacoepidemiology
Review
Published on 04 Jan 2023
in Pharmacoepidemiology
Brief Research Report
Published on 23 Dec 2022
in Pharmacoepidemiology
Original Research
Published on 21 Dec 2022
in Pharmacoepidemiology